Mirum Pharmaceuticals, Inc.
METHODS FOR TREATING CHOLESTASIS

Last updated:

Abstract:

Provided herein are methods for treating cholestasis in a subject having a liver disease. The method includes administering to the subject an Apical Sodium-dependent Bile Acid Transporter (ASBTI). More specifically, the present invention relates to methods for treating cholestasis in a subject where the method includes administering an ASBTI to a subject at a dose of at least 10 .mu.g/kg/day.

Status:
Application
Type:

Utility

Filling date:

17 Dec 2021

Issue date:

7 Apr 2022